Neuralink, a technology company founded by Elon Musk, has been given permission by the FDA to conduct human trials of its brain implant.
It says it does not have immediate plans to start recruiting participants. Mr Musk’s previous ambitions to begin tests came to nothing.
The company hopes that the implant will allow people to connect directly with computers, and Musk has previously suggested it could help people with disabilities to regain movement and vision.
Musk has also stated that he would trust the implant enough to allow his own children to receive it.
This was announced in a statement shared via the company’s official Twitter page on Thursday.
“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!” the tweet read. “This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.”
Musk also commented on the post on Friday, tweeting, “Congratulations to the Neuralink team.”